Lago, Baby Girl .
HRN: 21-95-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2022
OXACILLIN 500MG (VIAL)
10/13/2022
10/19/2022
IVT
63mg
Q6
Omphalitis, Neonatal Sepsis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes